2.1 CEO Report
The CEO Report was taken as read. The CEO reported to the Board on a number of the key significant areas as set out in the report.
In particular, discussions were held on the following aspects of the report.
Enhance primary and community services and reduce the need for people to attend hospital
The CEO informed the Board that the reform of Primary Care and specifically the building of the Enhanced Community Care (ECC) programme is progressing positively and that substantial progress that has been made despite the influence of the pandemic.
He noted that ECC has had substantial investment and is now starting to yield results. ICT and Recruitment are impacting overall program effectiveness, but all have mitigation plans in place. He informed the Board that a specific requirement has been set for September 2023 for the ECC model to provide an interface with both public and private nursing homes to improve hospital avoidance and to support post hospital discharge.
The Board welcomed this update noting the ECC programme demonstrates a significant opportunity for the future by providing the foundation and organisation structure through which integrated care is being enhanced. The Board welcomed the focus on implementing an end-to-end care pathway that provides care for people at home and over time prevent referrals and admissions to acute hospitals where it is safe and appropriate to do so. The Board discussed the importance of delivering the ECC programme to reorient service delivery towards general practice, primary care and community - based services.
Improve scheduled care to enable more timely access and reduce the number of people waiting for services
An update on performance in relation to scheduled care was provided, the CEO noted that while new referrals are ahead of expected demand the HSE has also been able to respond ahead of planned activity and this has mitigated the impact of the extra additions. He noted overall National Service Plan (NSP) target position on waiting list in terms of waiting times shows only a minor variation from target. The CEO informed the Board that a review of the projections and robustness of the planning data for Emergency Department projections is currently being carried out and he will report further on this matter in due course.
In response to questions from Board members on the development of surgical hubs and elective hospitals the CEO informed them that the completion of business cases for two sites is expected to be finalised in October 2023. The Board sought an update regarding early intervention for children with Scoliosis and the CEO undertook to circulate a briefing note on the up-to-date position to Board members on this.
Prioritise early interventions and improve access to person-centred mental health services
While noting that many aspects of the responses to mental health services are very positive, the CEO confirmed that the reform of mental health services as a delivery system is most challenged in the area of CAMHS, which the CEO has previously reported to the Board.
He noted that he met with the Chief Inspector of the Mental Health Commission (MHC) and that the MHC reported good co-operation from the HSE in regard to a MHC report which is due to be published in July. He advised, however, that it is expected that the report will set out a number of significant observations for childrens services in the areas of consistency of approach, lack of integrated service delivery, waiting lists, leadership and a more positive observation of more monitoring leading to decreased risk.
Urgent Care Challenges (including June Bank Holiday Weekend)
The Board considered the continued service challenges in respect of urgent care and noted that the upcoming bank holiday weekend could result in the service being put into a very difficult position. In an aim to plan and support the system during the bank holiday period the CEO informed the Board that he had made a direct intervention with the operational system to develop an approach to the challenge. The Board were briefed on the ongoing engagement between the DoH and the HSE regarding workforce reform rostering services including proposals for a 5 / 7 rostering service. The CEO has had discussions with the Minister and the Secretary General to advance very detailed proposals in the coming three to four weeks to ensure a key element going into the next round of the public sector pay talks is to ensure that the health system has capacity to recruit and deploy on a 5 / 7 basis for every grade employed in the health service.
The CEO noted that it is the HSE’s intention for the health service to operate routinely on a 5 / 7 as opposed to a 5 / 5 and on-call basis. It is necessary to have the healthcare workforce, including management, allied health professionals, community nurses operating as a team and across multiple services in both acutes and community.
Safeguarding
The CEO informed the Board he has commenced discussions on the understanding of, and by the organisation, in regard to all aspects of safeguarding reporting and will revert to the Board on this in due course. He also agreed to liaise with the Chair of the Safety and Quality Committee regarding a recent NiRP Report.
National Screening Services
The Board were informed that the Coombe Hospital continue to pause HPV and cytology sample processing for Cervical Check pending conclusion of the accreditation process by the Irish National Accreditation Board (INAB). The Board were informed that with sample processing at the Coombe Hospital currently paused, all Cervical Check samples are being tested in Quest Diagnostics Inc. in the US.
The Board sought a time-bound plan for the conclusion of the matter and the CEO agreed to revert to the Board on this.
Reconfiguration of services at Our Lady’s Hospital Navan
The Board requested an update on the current position in respect of the reconfiguration of services at Our Lady’s Hospital Navan. The CEO agreed to follow up with the CCO and revert on this matter to the Chair of the Safety and Quality Committee.
Finance and Human Resource Management
The CEO noted that the financial position remains as indicated and discussed at the April Board meeting. He advised that the draft expenditure data indicates a deficit for the first three months of the year of €178m, signalling expenditure pressures, albeit these are lower than flagged in the NSP. He advised that there remains expenditure risks this year, particularly in Acutes.
The Department of Health and the HSE continue to work proactively to mitigate the financial risks in 2023. The CEO informed members of the Board that he has taken some steps on aspects of the pay bill which include a non nett growth at the corporate centre and a pause of senior management / administration (Grade 7) is ahead of target across the organisation. An analysis of year end forecasted financial position will be reported to the June Board meeting based on Q1 data.
Regarding the current HR position, the Board were informed that employment levels at the end of March 2023 showed that there were 139,838 WTE (equating to 158,582 personnel) directly employed in the provision of Health & Social Care Services by the HSE and that the various Section 38 hospitals & agencies and the March 2023 outcome is strongly ahead of target at +306 Whole Time Equivalents (WTE’s).
Regional Health Authorities (RHA’s)
The Board were informed that documentation regarding RHA’s is likely to progress from the Department of Health through Government process in June.
2.2 Board Strategic Scorecard 2023
The CEO presented the May Board Strategic Scorecard (BSS) 2023 for the March reporting period, as circulated prior to the meeting.
As agreed at the April Board meeting, due to data not being available to report a complete KPI suite to the Board in line with the monthly Board Strategic Scorecard submission timelines, KPI data is to be reported two months in arrears in the monthly Board Strategic Scorecard report, which will ensure a more complete view of progress and performance in the monthly reports.
The Board reviewed and approved the BSS for May 2023, reflecting March data, for submission to the Minister for Health.